Wan‐Ming Chen

1.2k total citations
135 papers, 750 citations indexed

About

Wan‐Ming Chen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wan‐Ming Chen has authored 135 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wan‐Ming Chen's work include Cardiac, Anesthesia and Surgical Outcomes (14 papers), Intensive Care Unit Cognitive Disorders (13 papers) and Diabetes Treatment and Management (12 papers). Wan‐Ming Chen is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (14 papers), Intensive Care Unit Cognitive Disorders (13 papers) and Diabetes Treatment and Management (12 papers). Wan‐Ming Chen collaborates with scholars based in China, Taiwan and Hong Kong. Wan‐Ming Chen's co-authors include Szu‐Yuan Wu, Jiaqiang Zhang, Mingyang Sun, Ben‐Chang Shia, Mingchih Chen, Dabing Ge, Panpan Li, Huawei Liang, Yeu‐Shiang Huang and Shengyuan Wang and has published in prestigious journals such as Brain, The Science of The Total Environment and Diabetes Care.

In The Last Decade

Wan‐Ming Chen

109 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan‐Ming Chen China 15 81 78 76 75 74 135 750
Yiting Yang China 16 89 1.1× 35 0.4× 164 2.2× 78 1.0× 55 0.7× 48 776
Yan Wen China 18 118 1.5× 131 1.7× 145 1.9× 61 0.8× 25 0.3× 71 1.0k
Yu-Sheng Chen China 19 75 0.9× 42 0.5× 165 2.2× 68 0.9× 54 0.7× 57 1.1k
Huiling Zhang China 17 78 1.0× 107 1.4× 81 1.1× 33 0.4× 67 0.9× 81 899
Chien‐Min Chen Taiwan 21 118 1.5× 70 0.9× 132 1.7× 47 0.6× 15 0.2× 84 1.2k
Chengliang Zhang China 20 144 1.8× 146 1.9× 688 9.1× 68 0.9× 33 0.4× 79 1.7k
Yu Guo China 16 189 2.3× 78 1.0× 168 2.2× 179 2.4× 32 0.4× 101 1.3k
Yiran Wang China 19 71 0.9× 111 1.4× 299 3.9× 36 0.5× 55 0.7× 62 1.0k
Lei Du China 15 131 1.6× 101 1.3× 81 1.1× 80 1.1× 21 0.3× 67 710
Hui Zhong China 20 73 0.9× 50 0.6× 230 3.0× 50 0.7× 51 0.7× 77 1.3k

Countries citing papers authored by Wan‐Ming Chen

Since Specialization
Citations

This map shows the geographic impact of Wan‐Ming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Ming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Ming Chen more than expected).

Fields of papers citing papers by Wan‐Ming Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Ming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Ming Chen. The network helps show where Wan‐Ming Chen may publish in the future.

Co-authorship network of co-authors of Wan‐Ming Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Ming Chen. A scholar is included among the top collaborators of Wan‐Ming Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Ming Chen. Wan‐Ming Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Mingyang, Xiaolin Wang, Zhongyuan Lu, et al.. (2025). Chronic Postsurgical Pain Raises Risk of Dementia. European Journal of Pain. 29(4). e70002–e70002. 3 indexed citations
3.
Sun, Mingyang, Xiaoling Wang, Zhongyuan Lu, et al.. (2025). SGLT2is Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head- to-Head Comparative Study. Diabetes Care. 48(8). 1361–1369.
4.
Wang, Xiaolin, Zhongyuan Lu, Yi Yang, et al.. (2025). Metformin vs. second-line therapy for delirium prevention in type 2 diabetes: A multinational study. Diabetes Research and Clinical Practice. 225. 112270–112270. 1 indexed citations
5.
Lu, Zhongyuan, Mingyang Sun, Wan‐Ming Chen, et al.. (2025). Metformin’s impact on delirium in diabetic cardio surgery patients. Journal of Anesthesia. 39(4). 562–576. 1 indexed citations
6.
Chen, Wan‐Ming, et al.. (2024). Predictive value of ultrasonic artificial intelligence in placental characteristics of early pregnancy for gestational diabetes mellitus. Frontiers in Endocrinology. 15. 1344666–1344666. 3 indexed citations
7.
Lei, Meng‐Huan, et al.. (2024). Assessing mortality risk in Type 2 Diabetes patients with prolonged ASCVD risk factors: the inclusive Poh-Ai predictive scoring system with CAC Score integration. Diabetology & Metabolic Syndrome. 16(1). 104–104. 1 indexed citations
8.
Lu, Zhongyuan, Wan‐Ming Chen, Yi Yang, et al.. (2024). Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management. Diabetes Obesity and Metabolism. 26(9). 3914–3925. 4 indexed citations
9.
10.
Sun, Mingyang, Xiaoling Wang, Zhongyuan Lu, et al.. (2024). Metformin Use and Risk of Delirium in Older Adults With Type 2 Diabetes. Diabetes Care. 48(7). 1172–1179. 11 indexed citations
11.
Chen, Tsung-Ming, Wan‐Ming Chen, Mingchih Chen, Ben‐Chang Shia, & Szu‐Yuan Wu. (2023). Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning. Journal of Otolaryngology - Head and Neck Surgery. 52(1). 14–14. 2 indexed citations
13.
Chen, Wan‐Ming, et al.. (2023). Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients: Exploring dose, class, and intensity. Diabetes and Vascular Disease Research. 20(6). 1497057195–1497057195. 1 indexed citations
14.
Sun, Mingyang, Wan‐Ming Chen, Szu‐Yuan Wu, & Jiaqiang Zhang. (2023). Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction. Brain. 147(4). 1474–1482. 34 indexed citations
15.
Chen, Wan‐Ming, et al.. (2023). Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus. Pharmaceuticals. 16(4). 507–507. 4 indexed citations
16.
Lin, Chih‐Lang, et al.. (2023). The Protective Effect of Vitamin D on Dementia Risk in Hemodialysis Patients. Life. 13(8). 1741–1741. 3 indexed citations
17.
Lu, Zhongyuan, et al.. (2023). Sarcopenia and diabetes-induced dementia risk. Brain Communications. 6(1). fcad347–fcad347. 3 indexed citations
19.
Chen, Wan‐Ming, et al.. (2022). Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma. Cancers. 14(10). 2553–2553. 7 indexed citations
20.
Soong, Ruey‐Shyang, et al.. (2022). A Novel Predictive Scoring System for 90-Day Mortality among Patients with Hepatocellular Cell Carcinoma Receiving Major Hepatectomy. Cancers. 14(6). 1398–1398. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026